Compare RVMD & ULS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RVMD | ULS |
|---|---|---|
| Founded | 2014 | 1894 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.2B | 15.4B |
| IPO Year | 2020 | 2024 |
| Metric | RVMD | ULS |
|---|---|---|
| Price | $96.84 | $71.47 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 8 |
| Target Price | ★ $102.63 | $80.38 |
| AVG Volume (30 Days) | ★ 5.7M | 1.1M |
| Earning Date | 02-25-2026 | 02-19-2026 |
| Dividend Yield | N/A | ★ 0.74% |
| EPS Growth | N/A | ★ 10.58 |
| EPS | N/A | ★ 1.67 |
| Revenue | N/A | ★ $3,003,000,000.00 |
| Revenue This Year | N/A | $7.21 |
| Revenue Next Year | $740.40 | $5.56 |
| P/E Ratio | ★ N/A | $42.28 |
| Revenue Growth | N/A | ★ 6.68 |
| 52 Week Low | $29.17 | $49.34 |
| 52 Week High | $124.49 | $91.95 |
| Indicator | RVMD | ULS |
|---|---|---|
| Relative Strength Index (RSI) | 45.96 | 38.45 |
| Support Level | $96.72 | $68.62 |
| Resistance Level | $98.64 | $71.86 |
| Average True Range (ATR) | 3.97 | 2.21 |
| MACD | -3.23 | -0.23 |
| Stochastic Oscillator | 12.07 | 28.40 |
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.
UL Solutions is a global leader specializing in a broad range of product testing, inspection, and certification services. UL Solutions is the for-profit branch out of three organizations under the UL Enterprise. TIC operations make up nearly all of UL Solutions' total revenue and are composed of two segments: industrial and consumer. UL Solutions' remaining business includes software and advisory, which complements its core TIC offerings. The firm operates globally.